Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit).
Celalettin UstunElizabeth MorganErica E M MoodieSheeja PullarkatCecilia C S YeungSigurd Broesby-OlsenRobert OhgamiYoung KimWolfgang SperrHanne VestergaardDong ChenPhilip M KluinMichelle DolanKrzysztof MrózekDavid CzuchlewskiHans-Peter HornyTracy I GeorgeThomas Kielsgaard KristensenNam K KuCecilia Arana YiMichael Boe MøllerGuido MarcucciLinda BaughnAna-Iris SchieferJ R HilberinkVinod PullarkatRyan ShanleyJessica KohlschmidtJanie CoulombeAmandeep SalhotraLori SomaChristina ChoMichael A LindenCem AkinJason GotlibGregor HoermannJason HornickRyo NakamuraJoachim DeegClara D BloomfieldDaniel WeisdorfMark R LitzowPeter ValentGerwin HulsMiguel-Angel PeralesGautam BorthakurPublished in: Cancer medicine (2018)
I-CBFit composed of readily available risk factors can be useful to tailor the therapy of patients, especially for whom alloHCT is not need in CR1 (ie, patients with a low-risk I-CBFit score).